These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3928331)

  • 1. [Effect of dopaminergic pharmacological agents on thyrotropic hormone secretion by the hypophysis when stimulated with thyrotropin-releasing hormone].
    Boiadzhieva N; Zakharieva B; Ovcharov R
    Eksp Med Morfol; 1985; 24(1):29-32. PubMed ID: 3928331
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of dopamine energic pharmacology drugs on secretion of the adrenocorticotropic hormone from the hypophysis.
    Milkov V; Pironcheva G; Miteva K; Russev G; Zlatarev S
    Microbios; 2000; 102(403):155-8. PubMed ID: 10955829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
    Ishibashi M; Yamaji T
    J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of bromocrytine on the secretion of thyrotropic hormone and growth hormone (author's transl)].
    Pombo M; Feliu L; Martínez-Sapiña MJ; Martínez MD; Alvez F; Iglesias-Diz JL; Devesa J; Bravo M; Pereira J; Tojo T
    An Esp Pediatr; 1980 Jun; 13(6):497-502. PubMed ID: 6774646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopaminergic control of TSH secretion in isolated rat pituitary cells.
    Foord SM; Peters J; Scanlon MF; Rees Smith B; Hall R
    FEBS Lett; 1980 Dec; 121(2):257-9. PubMed ID: 6780375
    [No Abstract]   [Full Text] [Related]  

  • 6. Central dopaminergic and serotoninergic systems in the regulation of adrenal tyrosine hydroxylase.
    Quik M; Sourkes TL
    J Neurochem; 1977 Jan; 28(1):137-47. PubMed ID: 13151
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies of the thyrotropic function of the adenopituitary of the offspring of rats treated during pregnancy with dopaminergic agents.
    Boyadjieva M; Zaharieva B; Ovtcharov R
    Acta Physiol Pharmacol Bulg; 1988; 14(3):63-6. PubMed ID: 3223296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolactin secretion in Parkinson disease.
    Eisler T; Thorner MO; MacLeod RM; Kaiser DL; Calne DB
    Neurology; 1981 Oct; 31(10):1356-9. PubMed ID: 6810204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for dopaminergic control of thyrotrophin secretion in the rat.
    Ranta T; Männistö P; Tuomisto J
    J Endocrinol; 1977 Mar; 72(3):329-35. PubMed ID: 404378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative assessment of the specific activity of several thyrotropin-releasing-hormone analogs].
    Morozova LG; Smirnova AP; Shvachkin IP; Fedotov VP
    Biull Eksp Biol Med; 1976 Jun; 81(6):745-7. PubMed ID: 821571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of dopamine receptor agonists on gastric acid secretion induced by intraventricular administration of thyrotropin-releasing hormone in the perfused stomach of anaesthetized rats.
    Maeda-Hagiwara M; Watanabe K
    Br J Pharmacol; 1983 May; 79(1):297-303. PubMed ID: 6135480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proceedings: The effect of thyrotrophin releasing factor on the secretion of thyroid stimulating hormone and prolactin from the chicken anterior pituitary gland.
    Bolton N; Chadwick A; Scanes CG
    J Physiol; 1974 Apr; 238(1):78P-79P. PubMed ID: 4209906
    [No Abstract]   [Full Text] [Related]  

  • 13. Catecholaminergic control of alpha-melanocyte-stimulating hormone (alpha MSH) release by frog neurointermediate lobe in vitro: evidence for direct stimulation of alpha MSH release by thyrotropin-releasing hormone.
    Tonon MC; Leroux P; Stoeckel ME; Jegou S; Pelletier G; Vaudry H
    Endocrinology; 1983 Jan; 112(1):133-41. PubMed ID: 6401174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is a dopaminergic system involved in thyrotropin releasing hormone induced hyperthermia and in its potentiation by amphetamine?
    Rips R; Desiles M; Puech AJ
    Prog Neuropsychopharmacol; 1979; 3(4):337-44. PubMed ID: 45568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyrotropin-releasing hormone stimulated pituitary and thyroid gland responsiveness and 3,5,3'-triiodothyronine suppression in fetal and neonatal lambs.
    Klein AH; Fisher DA
    Endocrinology; 1980 Mar; 106(3):697-701. PubMed ID: 6766384
    [No Abstract]   [Full Text] [Related]  

  • 16. Resumption of prolactin secretion after dopaminergic inhibition: differential effects of dopamine and its agonists.
    Woolf PD
    Am J Physiol; 1981 Jun; 240(6):E700-4. PubMed ID: 7246736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of hypothalamic dopamine on growth hormone-releasing hormone-induced growth hormone secretion and thyrotropin-releasing hormone-induced prolactin secretion in goats.
    Jin J; Hashizume T
    Anim Sci J; 2015 Jun; 86(6):634-40. PubMed ID: 25442325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of dopaminergic drugs on pituitary hormone release in normal subjects.
    Sekso M; Solter M; Banovac K; Vizner B; Petek M
    Acta Med Iugosl; 1977; 31(4):321-32. PubMed ID: 596235
    [No Abstract]   [Full Text] [Related]  

  • 19. Hypothalamic dopamine is required for salsolinol-induced prolactin secretion in goats.
    Hashizume T; Watanabe R; Inaba Y; Sawai K; Fülöp F; Nagy GM
    Anim Sci J; 2017 Oct; 88(10):1588-1594. PubMed ID: 28556305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroendocrine function in schizophrenia.
    Brambilla F
    Acta Psychiatr Belg; 1980; 80(4):421-35. PubMed ID: 6792866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.